Home › NDC Lookup › RxCUI directory › RxCUI 1598082

20 ML peramivir 10 MG/ML Injection — RxCUI 1598082

RxNorm drug concept · Semantic clinical drug
RxCUI 1598082 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1598082
Official name20 ML peramivir 10 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asperamivir 200 MG per 20 ML Injection; peramivir 200 MG in 20 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Peramivir Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Rapivab works by blocking an enzyme the flu virus uses to spread inside your body. Unlike oral flu medications such as oseltamivir (Tamiflu), Rapivab is given as a single one-time...
  • What exactly does Rapivab do, and how is it different from other flu treatments?
  • No — Rapivab is designed as a single dose. You receive one IV infusion over about 15 to 30 minutes, and that's it. There's no follow-up dose needed. The key is getting it early, wi...
  • The most common side effect is diarrhea, which is generally mild. Some lab values — like blood sugar, a liver enzyme, and a muscle enzyme — can go up slightly, but these are usuall...
📖 Read our full Peramivir Injection guide →

🕸️ Concept Web — How 20 ML peramivir 10 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 20 ML peramivir 10 MG/ML Injection RxCUI 1598082

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Peramivir 619693
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rapivab 1598078
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Peramivir Injection 1724184
    • Peramivir Injectable Product 1161399
    • Peramivir Injection [Rapivab] 1724186
    • Rapivab Injectable Product 1598081
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Peramivir 10 MG/ML SCDC · 876201
  • Peramivir Injection SCDF · 1724184
  • Peramivir Injectable Product SCDG · 1161399

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1598082 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72769-0181-03 3 VIAL, GLASS in 1 CARTON (72769-181-03) / 20 mL in 1 VIAL,... Rapivab BioCryst Pharmaceuticals, Inc. 2014-12-20
Observed labelers: BioCryst Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.